Lippis Daniel J. bought EW
March 7, 2024 · Form 4 insider transaction
Lippis Daniel J. bought 1,715 shares of Edwards Lifesciences Corporation at $36.75 per share, a transaction worth $63.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,715
Price
$36.75
Total value
$63.0K
InsiderLippis Daniel J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 7, 2024
Filing dateMarch 7, 2024
Shares owned after18,928
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.